期刊文献+

乙酰肝素酶与动脉粥样硬化 被引量:1

Heparanase and atherosclerosis
下载PDF
导出
摘要 动脉粥样硬化是致死率较高的常见心血管疾病,乙酰肝素酶是能够裂解细胞外膜中硫酸乙酰蛋白多糖上侧链乙酰肝素的一种内切性β-D-葡萄糖醛酸糖苷酶,且其非酶活性也在许多正常生理活动或病理疾病中发挥作用。研究表明乙酰肝素酶与动脉粥样硬化的形成和进展有着紧密的联系。本文综述了乙酰肝素酶损伤内皮、促凝、诱导炎症因子及脂质聚集等作用,并阐述其在动脉粥样硬化发生发展中的作用及机制。 Atherosclerosis is a common cardiovascular disease with high mortality.Heparanase is an endogenousβ-D-glucuronidase that can cleave the upper side chain of acetylproteoglycan sulfate in the outer membrane of the cell.And its non-enzymatic activity also plays a role in many normal physiological activities or pathological diseases.Studies have shown that heparanase is closely related to the formation and progression of atherosclerosis.This paper reviews the effects of heparanase on endothelial injury,coagulation,inflammatory factors and lipid accumulation,and expounds its role and mechanism in the occurrence and development of atherosclerosis.
作者 刘芮宏 王蒙琴 韩轩茂 LIU Ruihong;WANG Mengqin;HAN Xuanmao(Graduate School,Baotou Medical College,Inner Mongolia University of Science and Technology,Baotou,Inner Mongolia 014040,China;Department of Cardiology,the First Affiliated Hospital of Baotou Medical College,Inner Mongolia U niversity of Science and Technology,Baotou,Inner Mongolia 014040,China)
出处 《中国动脉硬化杂志》 CAS 2022年第3期255-259,共5页 Chinese Journal of Arteriosclerosis
基金 内蒙古自治区自然科学基金(2017MS0860)。
关键词 乙酰肝素酶 动脉粥样硬化 糖萼 heparanase atherosclerosis endothelial glycocalyx layer
  • 相关文献

参考文献2

二级参考文献41

  • 1Li YJ, Li SL. Muscular characteristic of heparanase and its function in physiological and pathological process[J]. J Henan Univ:Med Sei,2008,27(3) : 14-19.
  • 2Baraz L, Haupt Y, Elkin M, et al. Tumor suppressor p53 regulates heparanase gene expression[J]. Oneogene, 2006, 25(28) : 3939-3947.
  • 3de Mestre AM, Rao S, Hornby JR, et al. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cell[J]. J BiolChem, 2005, 280(42): 35136-35147.
  • 4Elkin M, Cohen I, Zcharia E, et al. Regulation of heparanase gene expression by estrogen in breast cancer[J]. Cancer P, es, 2003, 63(24): 8821-8826.
  • 5Chen G, Wang D, Vikramadithyan R, et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression[J]. Biochemistry, 2004, 43(17) : 4971-4977.
  • 6Hoogewerf AJ, Leone JW, Reardon IM, et al. CXC chemokines connective tissue activating peptide-Ⅲ and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes[J]. J Biol Chem, 1995, 270(7): 3268-3277.
  • 7Dempsey LA, Plummer TB, Coombes SL, et al. Heparanase expression in invasive trophoblasts and acute vascular damage[J]. Glycobiology, 2000, 10(5): 467-475.
  • 8Lerner I, Hermano E, Zcharia E, et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice[J]. J Clin Invest, 2011, 121 (5): 1709- 1721.
  • 9Zhang X, Wang B, O'Callaghan P, et al. Heparanase overexpression impairs inflammatory response and macrophage- mediated clearance of amyloid-β in murine brain [ J ]. Acta Neuropathol, 2012, 124(4): 465-478.
  • 10Waterman M, Ben-Izhak O, Eliakim R, et al. Heparanase upregulation by colonic epithelium in inflammatory bowel disease [J]. ModPathol, 2007, 20(4): 8-14.

共引文献10

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部